Tag Archives: Obama

Part D Politics: Medicare Drug Rebates or Price Controls?

Jill Wechsler Blog – PE Feb. 22, 2013 Part D Politics:  Medicare drug rebates or price controls? While health care was barely mentioned in the recent State of the Union address, President Obama generated some interest in his proposal to cut Medicare spending by reducing “taxpayer subsidies to prescription drug companies.” That’s code for requiring pharma marketers to pay [...]
Posted in Op-Ed, Regulatory, healthcare, pricing | Also tagged , , , | Leave a comment

Governor Howard Dean: Financing the Future of US Drug Innovation

Will it be More Good Pills — Or that Porsche? The Obama Administration’s signal achievement to date — passage of comprehensive health reform legislation — continues to inspire confusion and contradictions across the political spectrum. Despite its scope, the bill is dismissed by many Democrats for what it does not do, while the GOP [...]
Posted in FDA, R&D, Regulatory, healthcare | Also tagged , , , , | 1 Comment

Daschle Ditches HHS Nomination

In light of the controversy surrounding his tax records, Tom Daschle withdrew his nomination for Secretary of Health and Human Services (HHS) Tuesday. But by throwing Daschle’s nod out the window, it could drag any hope for healthcare reform in 2009 with it. Daschle seemed like a shoe in for the HHS position from the start [...]
Posted in People | Also tagged , , , | Leave a comment

Memo to President Obama on Reforming FDA

In recent weeks, the incoming Obama administration has solicited input from across the policy community as it begins to shape priorities for its forthcoming term. As a former FDA official, I was honored to be asked for my advice on the pharma industry. Demand for drugs is on the rise, yet FDA remains undermanned, underfunded, and [...]
Posted in Regulatory | Also tagged , , , , , | Leave a comment